English Elm (Ulmus procera)
1. Identity and Botanical Description
Taxonomy and Nomenclature
English elm is a large deciduous tree belonging to the family Ulmaceae. Its accepted botanical name is Ulmus procera Salisb. (Salisbury, 1796), though it carries a substantial number of synonyms that reflect longstanding taxonomic debate. The species has historically been listed as Ulmus campestris L. (pro parte) and U. minor auct. non P. Mill. Ulmus procera is very closely related to Ulmus minor and is sometimes treated as a form of that species, known as Ulmus minor var. vulgaris Richens, and sometimes as a single clone or cultivar (Ulmus minor 'Atinia'). Additional accepted synonyms registered in the Euro+Med Plantbase include Ulmus campestris subsp. procera (Salisb.) Maire and Ulmus minor subsp. procera (Salisb.) Franco.
The common name "English elm" is the most widely used in Britain, but the tree has also been called Common Elm and Worcester Weed. Traditional varieties grouped as medicinal elms include U. procera (English Elm), U. campestris (Wild Elm), U. laevis (White Elm), and U. montanus (Mountain Elm), with bark and leaf considered the primary medicinal parts.
Morphology
English elm is a deciduous tree growing up to 35 metres tall, exceptionally to 45 metres. The crown is broadly columnar, the trunk extending well into the crown, and suckers are present. The bark is grey-brown, rough and fissured, often with suckers growing from the base of the trunk; the twigs and oval pointed buds are covered in fine, reddish hairs. The leaves are dark green, approximately 4–9 cm in length, sharply double-toothed, hairy and rough to touch on the top surface, round to oval with a characteristic asymmetrical base, tapering to a sharp point, and turn butter-yellow in autumn. Flowers, rarely if ever produced, are dark pink to red and hang in tassels, appearing between February and March, and once pollinated by wind develop into tiny winged fruits known as samaras. Seeds are usually sterile; most populations are formed by suckering plants growing from nearby parent trees.
Distribution and Ecological Status
English elm is native to Europe and is grown as an ornamental in other parts of the world, including being naturalised in parts of Victoria, Australia. English elm once dominated the British landscape but has been ravaged by Dutch elm disease since the 1960s; it is now only found occasionally in hedgerows or woodland, mainly in England and Wales. The English elm is particularly susceptible to Dutch elm disease, a disease that has destroyed the greater part of all elm trees growing in Britain.
Common Preparations and Forms
In the historical herbal tradition, bark and leaf were considered the primary medicinal parts of the elm. Traditional preparations documented in classical herbals include decoctions of the bark (in water and/or wine), bark poultices, infusions of the leaf, and water distilled from the blisters found in the leaves. In the context of broader elm ethnobotany, inner bark preparations — including dried and powdered bark, bark decoctions, and bark infusions — have been the most frequently employed forms across the genus.
In contemporary commerce, Ulmus procera flowers are used in the Bach Flower Remedy system: products registered with the U.S. FDA under the DailyMed database list Ulmus procera, Flos at homeopathic potencies (6X, 30C, 200C) for the claim of "temporary relief of being overwhelmed by responsibility." Such homeopathic products have not been evaluated by the FDA for safety or efficacy, and the FDA is not aware of scientific evidence supporting homeopathy as effective. These preparations are wholly distinct from any phytotherapeutic or herbalistic use of the plant's bark, leaf, or other material parts.
2. Traditional and Historical Use
Ancient and Classical Mediterranean Traditions
The medicinal use of elm bark has a long documented history in European medicine. Avicenna (Ibn Sina, c. 980–1037 CE) classified elm as cold and dry in temperament. Medieval herbalists, including Matthiolus (writing in the Kreuterbuch, 1563 and 1586), documented that a decoction of the bark in water and wine cleanses phlegm, and that full doses were used to purge phlegm.
Medieval European Tradition
In the 12th century, Abbess Hildegard von Bingen (1098–1179) wrote of elm as a remedy for what she termed "gicht" (a term encompassing conditions resembling arthritis or gout) and associated convulsive disorders. Hildegard wrote that one troubled by gicht should warm himself by a fire burning only elm wood; that fresh new leaves of the elm tree should be placed in water and administered as a drink to one whose tongue fails to speak; and that one with "freislich" should frequently drink water tempered with the leaves.
Western European Herbal Tradition (16th–19th Century)
Nicholas Culpeper (1616–1654), in The Complete Herbal, a historical medicinal guide written in the mid-17th century that combines herbalism, astrology, and early medical practices, documented the medicinal properties of various plants including elm. Culpeper recorded a particularly striking preparation: a water distilled from the blisters found on elm leaves, sealed in glass and buried in the earth for twenty-five days over a bed of salt, was described (in his words, also cited in the Medicine Traditions database) as a "singular and sovereign balm for green [fresh] wounds." A hip bath preparation of elm bark with alum was also recorded for excessive menstruation.
The 19th-century Eclectic and mainstream European medical traditions used elm bark extensively. King's American Dispensatory (drawing on elm bark from various Ulmus species including European varieties) noted that the bark contains a bitter glucoside not yet isolated, much mucilage, some resin, and iron-greening tannin; the bark was described as cinnamon-colored on both sides with a bitterish, astringent, and mucilaginous taste.
Elm bark was incorporated into numerous 19th-century formularies for conditions including diarrhea (combined with oak bark and tormentil), "blood cleansing" preparations (combined with bittersweet, fumitory, burdock root, and red dock root in the Formulaire Magistral et Memorial Pharmaceutique, 1823), and as an ingredient in Sarsaparilla-based compound preparations described in the Model Botanic Guide to Health.
Elm bark was used both internally and externally in the treatment of diarrhea, rheumatism, wounds, and piles, and also as a mouthwash in the treatment of ulcers. The leaves of English elm were also shredded and used as cattle fodder.
Relationship to the Broader Elm Genus
It is important to note that the historical European herbal tradition did not sharply distinguish between species within the genus Ulmus, and bark preparations were often used interchangeably across English elm, field elm (U. minor), wych elm (U. glabra), and white elm (U. laevis). The most rigorously studied member of the genus in modern medical terms is the North American Ulmus rubra (slippery elm), and East Asian species including U. davidiana, U. pumila, U. macrocarpa, and U. wallichiana. The genus Ulmus contains more than 40 species, naturally distributed throughout the northern hemisphere in Eurasia, North America, Central America, and Northern Africa. Scientific evidence generated on these related species is directly relevant to understanding the chemistry of English elm, although it cannot be extrapolated to English elm without qualification.
3. Key Constituents and Active Compounds
Phytochemical Classes Across the Ulmus Genus
Previous phytochemical investigations on the genus Ulmus have identified diverse types of compounds, including flavonoids, terpenoids, lignans, coumarins, and glycosides. Secondary metabolites in the aerial parts of Ulmus plants are generally categorized into catechin glycosides (CG) and flavonoid glycosides (FG). The Ulmus genus has been utilized in traditional Eastern medicine for a significant time.
Work on U. pumila bark, which is more fully characterized than U. procera, demonstrates the range of compounds expected in bark of this genus. Phytochemical investigations of U. pumila bark have revealed the presence of flavonoids, triterpenoids, sesquiterpenoids, monosaccharides, and sterols. Thirty-two compounds have been isolated from the leaves of U. pumila, of which twenty were isolated from Ulmaceae for the first time; flavonoids, terpenoids, and phenolics are among the compound classes identified.
Catechins and Catechin Glycosides
Catechins and their glycoside derivatives are among the most consistently identified bioactive compounds across the Ulmus genus. Secondary metabolites including catechin, catechin-7-O-α-L-rhamnopyranoside, catechin-3-O-α-L-rhamnopyranoside, lyoniside, (−)-lyoniresinol, and (+)-lyoniresinol nudiposide have been reported in the root bark of U. davidiana var. japonica. Moreover, (−)-catechin-7-O-β-D-apiofuranoside, (−)-catechin, procyanidin B3, phloridzin, fraxetin, isovanillic acid, and vanillic acid have been isolated from the root bark of U. parvifolia.
A key compound of interest across the genus is catechin-7-O-β-D-apiofuranoside (sometimes called ulmoside). Studies on U. davidiana root bark have isolated (+)-catechin, catechin-7-O-β-apiofuranoside, icariside E4, protocatechuic acid, and other phenolic compounds.
Flavonoids and Flavanones
Phytochemical investigation of U. davidiana var. japonica root bark has led to isolation of catechin derivatives, megastigmane glycosides, dihydrochalcone glycosides, flavanone glycosides, coumarins, lignan derivatives, and phenolic compounds.
From U. macrocarpa, six flavonoid compounds have been characterized: (2S)-naringenin-6-C-β-d-glucopyranoside, (2R)-naringenin-6-C-β-d-glucopyranoside, (2R,3S)-catechin-7-O-β-d-xylopyranoside, (2R,3S)-catechin-7-O-β-d-apiofuranoside, (2R,3R)-taxifolin-6-C-β-d-glucopyranoside, and (2S,3S)-taxifolin-6-C-β-d-glucopyranoside.
Tannins
King's American Dispensatory noted the presence of "iron-greening tannin" in elm bark — a characteristic of hydrolysable tannins that form dark complexes with ferric salts. Tannins are polyphenolic compounds with established astringent and antioxidant properties. Phytochemical analyses of U. pumila root bark show a relatively strong presence of phenolics, steroids, and terpenoids.
Mucilage
Mucilage — complex polysaccharide material — is a characteristic constituent of inner elm bark across the genus. In U. rubra (slippery elm), the most closely studied analogue for this class of constituent, the inner bark is harvested to produce a commercial drug known for its mucilage content, which possesses demulcent, emollient, and nutritive properties. These complex soluble carbohydrates decrease intestinal transit time, decrease absorption of drugs, sugar, and other digestible contents of the gastrointestinal tract, bind lipids, and benefit indigenous bacterial populations. The mucilage of European elm bark was described as resembling that of flaxseed (Braconnot, 1846).
Lignans and Other Phenolics
Flavonoids and coumarins have been isolated from the root bark of U. macrocarpa. Lignan and neolignan glycosides have also been documented from U. davidiana var. japonica (Lee et al., 2001, cited in multiple sources), and sesquiterpenoid-naphthaquinone conjugates have been identified from U. davidiana root bark. Fermentation studies of U. davidiana var. japonica root bark extracts confirmed the presence of catechin, epicatechin, quercetin, and kaempferol by HPLC analysis.
4. Mechanisms of Action
Direct mechanistic studies on Ulmus procera specifically are absent from the peer-reviewed literature. The following mechanisms are established for related Ulmus species and their isolated compounds, and represent hypotheses — not established facts — for English elm.
Demulcent and Mucoprotective Action
Mucilage polysaccharides in elm bark form viscous gels upon hydration. Mucilage quickly swells into a gooey mass when exposed to water, thereby ameliorating dry or mildly inflamed skin; it also dries as a mild adhesive and can be used as an herbal bandage for minor wounds. In the gastrointestinal tract, this physical film-forming action is understood to coat mucosal surfaces, reducing mechanical irritation.
Astringent Action (Tannins)
Tannins in elm bark act through protein precipitation and free-radical scavenging. Tannins in elm preparations can reduce inflammation by acting as astringents. This astringent property may contribute to anti-diarrheal effects by reducing mucosal secretion and toning intestinal tissues.
Anti-Inflammatory Mechanisms
Studies on Ulmus species extracts have identified inhibition of inflammatory signaling pathways. In studies on phenolic compounds from U. macrocarpa roots, nitric oxide production was reduced and the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and their mRNA were inhibited by addition of the isolated compounds. Catechin isolated from U. davidiana var. japonica root bark extract was reported to inhibit the accumulation of intracellular reactive oxygen species (ROS) in TNF-α-stimulated normal human dermal fibroblasts.
Osteoclast Inhibition and Bone-Related Mechanisms
Flavonoid glycosides from U. macrocarpa may exhibit osteoclast differentiation inhibitory activity via the downregulation of NFATc1, a master regulator involved in osteoclast formation, providing further scientific evidence for the rational application of the genus Ulmus in the treatment of osteopenic diseases such as osteoporosis.
Antimicrobial Mechanisms
Sub-MIC concentrations of U. pumila root bark extract showed inhibition of the genetic expressions of virulence factors such as mecA, sea, agrA, and sarA in MRSA; phytochemical analyses showed a relatively strong presence of phenolics, steroids, and terpenoids, suggesting that antibacterial activity may be related to these phytochemicals.
5. Scientific Evidence by Area of Use
A critical preliminary note: as of the time of writing, no peer-reviewed clinical trials or systematic reviews have been conducted using Ulmus procera (English elm) specifically as a therapeutic agent in humans. All scientific evidence reviewed here pertains to related elm species — primarily U. davidiana, U. pumila, U. macrocarpa, U. wallichiana, and U. rubra. Attribution to English elm specifically is not scientifically warranted and is noted where relevant.
5.1 Digestive System / Gastrointestinal Health
The most relevant reviewed evidence for gastrointestinal use of elm bark comes from studies on Ulmus rubra (slippery elm). The active ingredients of elm bark appear to be mucilages, but the inner bark is also rich in tannins and resins which are astringents and may account for some of its effects; while not approved as therapy for any disease or condition, over-the-counter preparations are sold as demulcents and for gastrointestinal upset.
An in vitro study (Langmead et al., 2002) investigated antioxidant effects of herbal therapies used by patients with inflammatory bowel disease (IBD). The study investigated antioxidant effects using chemiluminescence to identify the effects of several herbs — including slippery elm, fenugreek, devil's claw, tormentil, and wei tong ning — on oxygen radicals in mucosal biopsies from patients with active ulcerative colitis; it is unclear whether the herbs were applied in combination or individually, but results showed that oxygen radical release from biopsies was reduced after incubation. This constitutes very preliminary in vitro evidence with significant methodological limitations; it does not establish clinical efficacy for any elm species.
Evidence rating (gastrointestinal): Preliminary. Evidence is limited to in vitro data and traditional use records; no controlled human clinical trials have evaluated English elm specifically for any gastrointestinal condition.
5.2 Bone Health / Osteoporosis
The most substantive scientific research on the Ulmus genus in the context of bone health has been conducted on U. wallichiana, U. davidiana, and U. macrocarpa.
A 2024 systematic review published in Fitoterapia (Jeong et al., PMID 39153558) investigated the therapeutic effects of Ulmus species extracts, traditionally used as tea ingredients in East Asia, on bone health and inflammatory conditions; through analysis of 9,757 studies narrowed to 56 pertinent ones, the review evaluated safety and efficacy of Ulmus extracts, focusing on catechin glycosides (CG) and flavonoid glycosides (FG); the research highlights the extracts' role in enhancing bone mineral density (BMD) by stimulating osteoblast activity and suppressing osteoclast differentiation, suggesting a protective effect against osteoporosis, and the extracts demonstrated significant anti-inflammatory properties by modulating inflammatory markers and pathways.
At the preclinical level, a novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon, was shown to mitigate ovariectomy-induced osteoporosis in rats (published in Menopause, 2010). The compound (GTDF) was shown to protect against glucocorticoid-induced bone loss by promoting osteoblast survival through p53 inhibition and activation of AKT pathways, with potential in the management of glucocorticoid-induced osteopenia.
These studies are conducted in cell culture models and animal models and have not been replicated in human clinical trials. Furthermore, they do not involve U. procera. Evidence rating (bone health): Preclinical only (in vitro and animal studies). No human clinical trials. Not directly applicable to English elm.
5.3 Antimicrobial Activity
An ethanol extract of Ulmus pumila root bark was tested against clinically isolated MRSA strains; the extract showed antibacterial activities against all tested MRSA strains, with minimum inhibitory concentration (MIC) values ranging from 125 to 250 μg/mL. The researchers noted that these results may provide scientific basis for the traditional use of U. pumila root bark against infectious diseases.
This is an in vitro study on a different species. Evidence rating (antimicrobial): Preliminary in vitro evidence for related species only. No clinical data.
5.4 Antioxidant Activity
Ulmus pumila has been reported to have antioxidant, anti-inflammatory, antimicrobial, and anti-adipogenic activities. Studies on U. davidiana var. japonica stem bark have investigated antioxidant activity. The stem bark of U. davidiana var. japonica, a deciduous tree used in traditional medicine, was examined for antioxidant and anti-inflammatory activity; phytochemical examination led to the isolation and characterization of (+)-catechin, (+)-catechin-7-O-β-D-apiofuranoside, and procyanidin B3; bioactivities including DPPH free radical scavenging activity and nitric oxide inhibition activity were evaluated.
These are all in vitro assays conducted on different elm species. Evidence rating (antioxidant): Preclinical/in vitro evidence for related species only.
5.5 Wound Healing and Skin Applications
The traditional use of elm bark poultice and decoction for wound healing draws on the mucilage and tannin content of the bark. The mucilage-based mechanism for wound care is plausible: mucilage quickly swells into a gooey mass when exposed to water, thereby ameliorating dry or mildly inflamed skin, and also dries as a mild adhesive that can be used as an herbal bandage for minor wounds.
No controlled clinical studies specifically evaluating U. procera bark preparations on wound healing in humans have been published. Evidence rating (wound healing): Mechanistically plausible based on constituent action, but no clinical trial evidence for English elm.
5.6 Rheumatism and Musculoskeletal Conditions
Elm bark was historically used for rheumatism, and anti-inflammatory properties of related species have been explored in vitro. The roots of Ulmus macrocarpa Hance have been used in oriental traditional medicine for the treatment of inflammation, ulcers, cancers, and parasites. However, no clinical trials address this use in English elm. Evidence rating: Traditional use record only; no clinical evidence for English elm.
6. Body Systems Associated with English Elm
- Gastrointestinal system: Historically used for diarrhea, dysentery, hemorrhoids, intestinal inflammation, and oral ulcers. The demulcent mucilage and astringent tannins in bark preparations provide plausible mechanisms for soothing gastrointestinal mucosa.
- Integumentary system (skin): Traditional topical use for fresh wounds, burns, scalds, and skin irritation. The film-forming properties of bark mucilage are consistent with emollient action.
- Musculoskeletal system: Historical use for rheumatism; preliminary in vitro evidence from related species suggests anti-inflammatory properties relevant to joint and connective tissue conditions.
- Skeletal system (bone): Flavonoid and catechin glycoside compounds from other elm species have demonstrated osteoblast-stimulating and osteoclast-inhibiting activity in preclinical models.
- Immune system: Anti-inflammatory and immunomodulatory activities have been demonstrated in vitro and in animal models for other Ulmus species; no human data exist for U. procera.
- Oral cavity: Bark infusion was traditionally used as a mouthwash for oral ulcers.
7. Dosage Forms and Reported Dosages
No formal dosage ranges have been established for Ulmus procera specifically in peer-reviewed clinical literature, as no clinical trials in humans have been conducted on this species. The following dosage information comes entirely from historical or pharmacopeial sources relating to the broader category of elm bark preparations:
- Homeopathic liquid preparation (Ulmus procera, Flos): Adults and children: 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. Note that this is a homeopathic product and these "doses" represent highly diluted preparations whose therapeutic status is not supported by scientific evidence.
- Bark decoction (historical, broad elm genus): No standardized dose for U. procera bark is established in peer-reviewed or pharmacopeial literature.
- Bark infusion for topical use: Historical sources describe application of thick tea made from powdered bark directly to wounds, burns, and ulcers, without defined quantities.
For comparator purposes, the most closely pharmacologically characterized elm preparation in clinical contexts is slippery elm (U. rubra), for which tablets, powder-filled capsules, lozenges, ground bark for teas, and poultices are found in health food stores. These preparations and their associated dosing guidance are specific to U. rubra and should not be generalized to U. procera.
8. Safety Considerations and Interactions
General Safety Profile
No systematic toxicological studies have been published on Ulmus procera bark or leaf preparations. Safety data for other elm species is available but cannot be automatically transferred to English elm.
Regarding the broader elm genus used in herbal medicine: while elm preparations are generally recognized as safe, they have not been formally assessed for hepatic adverse effects or elevations of serum aminotransferases, alkaline phosphatase, or bilirubin levels; despite common use, there have been no published case reports of liver injury attributed to elm preparations.
Drug Absorption Interactions
The mucilage content of elm bark is a known physical barrier in the gastrointestinal tract that may reduce the rate and extent of absorption of co-administered medications. Elm preparations can slow and/or inhibit absorption of other medications and should therefore be taken 2 hours before or after other medications. This interaction risk is a class effect of mucilaginous preparations and is not specifically established for U. procera but is reasonably inferred from constituent chemistry.
Allergenicity and Sensitization
Elm in the Ulmus genus has been reported as a sensitizer; the most common reactions include eye and skin irritation. Individuals with known hypersensitivity to other members of the Ulmaceae family should be aware of potential cross-reactivity.
Pregnancy and Uterine Stimulation
For the closely related slippery elm (U. rubra), folk medicine resources and anecdotal sources describe miscarriages in women inserting small strips of the bark into the cervical os, as the bark absorbed moisture and expanded. This historically documented physical mechanism of uterine stimulation (via bark expansion) is not a pharmacological action relevant to oral or topical bark preparations, but it has informed caution about elm use during pregnancy. No equivalent data exist for U. procera.
Wood Dust Occupational Hazard
From an occupational safety perspective, elm wood in the Ulmus genus has been reported as a sensitizer, and woodworkers processing English elm timber may be at risk for allergic contact dermatitis or respiratory sensitization from wood dust. This is distinct from any risk associated with medicinal bark preparations.
Absence of Clinical Pharmacokinetic Data
No pharmacokinetic studies, maximum tolerated dose studies, or drug–herb interaction studies specific to Ulmus procera have been published in peer-reviewed literature. All safety statements for this species are therefore either inferred from related species, from phytochemical class characteristics, or derive from historical use records, and should be understood as having low evidentiary weight.
9. Current Research Status and Evidence Gaps
Findings from research on the broader Ulmus genus confirm the historical use of elm extracts in East Asia for health benefits and recommend further exploration into functional foods and nutraceuticals. However, the specific species Ulmus procera has been almost entirely absent from this modern research agenda. The overwhelming majority of phytochemical, pharmacological, and clinical research on elm has focused on East Asian species (U. davidiana, U. pumila, U. macrocarpa, U. wallichiana) and the North American U. rubra.
Key evidence gaps for English elm specifically include: (1) a definitive phytochemical profile of U. procera bark and leaf; (2) any human pharmacokinetic or pharmacodynamic data; (3) controlled clinical trials for any indication; (4) formal toxicological assessment including genotoxicity, sub-chronic and chronic toxicity evaluations; and (5) any assessment of drug–herb interactions. Until these gaps are addressed, all claims about the medicinal properties of English elm specifically must be regarded as traditional use records, supported — at best — by biological plausibility derived from the broader genus.
References
Go back